Article
Immune escape mutations selected by neutralizing antibodies in natural HIV-1 infection can alter coreceptor usage repertoire of the transmitted/founder virus.
Virology - 1 Mar 2022
Marichannegowda Manukumar Honnayakanahalli, Song Hongshuo
Abstract excerpt
The ability of HIV-1 to evade neutralizing antibodies (NAbs) in vivo is well demonstrated, but the impact of NAb escape mutations on HIV-1 phenotype other than immune escape itself has rarely been studied. Here, we show that immune escape mutations selected by V3-glycan specific NAbs in vivo can alter coreceptor usage repertoire of the transmitted/founder (T/F) HIV-1. In a participant developed V3-glycan NAb...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
